CD8A and neoplasm: The necessity of CD8+ T cells in mediating the therapeutic response of terbinafine was further confirmed, as indicated that retarded tumor growth by terbinafine was not observed in mice with CD8+ T cell depletion (, figure 5E–G and online supplemental figure 5A).